Globe Life (GL) FY2025 10-K Annual Report
Globe Life (GL) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 25, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Globe Life FY2025 10-K Analysis
Business Overview
- • Insurance holding company selling life and supplemental health products to lower-middle-income Americans via direct-to-consumer and exclusive agent channels
- • Established Globe Life Re Ltd. in Bermuda in 2025 — new affiliated reinsurer registered as Class C insurer under BMA supervision for capital efficiency
- • Health insurance annualized premium in force grew to $1.65B in 2025 vs $1.48B in 2024, driven by United American Medicare Supplement (+$125.7M) and Family Heritage (+$41M)
- • 3,695 employees (1% decrease YoY); 17,000+ independent contracted agents across U.S., Canada, and New Zealand
- • $8M+ in charitable contributions in 2025, focused on children, families, veterans, and seniors
Management Discussion & Analysis
- • Total premium $4.9B, up 5% YoY; life premium $3.4B (+3%), health premium $1.5B (+9%)
- • Net income $1.16B vs $1.07B; net operating income ROE (ex-AOCI) 16.0% vs prior-year mid-teens target
- • Best segment: life underwriting margin $1.51B, 45% of premium vs 41% in 2024; worst: excess investment income $138M, down 16% YoY
- • Share repurchases 5.4M shares at $685M avg $126.41/share; quarterly dividend raised to $0.27 in 2025, projected $0.33 in 2026
- • 2026 subsidiary dividends and excess cash flows projected lower due to nonrecurring extraordinary dividends of $272M received in 2024–2025
Risk Factors
- • Legal proceedings costs $13.5M in 2025 and $17M in 2024, indicating ongoing material litigation exposure with no specific resolution timeline
- • Excess investment income fell 16% to $138M in 2025, driven by lower yields on commercial mortgage loans and limited partnerships and constrained asset growth
- • American Income Life Division contributes 53% of total life premium ($1.79B), creating heavy single-channel concentration risk
- • Medicare Advantage market shift boosted United American health net sales 92%, but underwriting margin compressed to 6% from 8% due to rising claims utilization
- • Fixed maturity portfolio 42% BBB-rated at $18.8B amortized cost, with $1.2B net unrealized loss position and effective duration of 8.7 years to next call
Globe Life FY2025 Key Financial MetricsXBRL
Revenue
$6.0B
▲ +3.7% YoY
Net Income
$1.2B
▲ +8.4% YoY
Net Margin
19.4%
▲ +84bp YoY
ROE
19.4%
▼ -75bp YoY
Total Assets
$30.8B
▲ +6.0% YoY
EPS (Diluted)
$14.07
▲ +17.8% YoY
Operating Cash Flow
$1.4B
▼ -0.4% YoY
Source: XBRL data from Globe Life FY2025 10-K filing on SEC EDGAR. All figures in USD.
Other Globe Life Annual Reports
Get deeper insights on Globe Life
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.